Health start-up SigTuple has raised $19 million in series B funding led by existing investors Accel Partners and IDG Ventures, along with an undisclosed amount of venture debt from Trifecta Capital. The Indian-based AI company will use the funding to expand production of its AI100 smart device, which digitises biological samples such as blood, urine and semen. The company has applied for the US Food and Drug Administration certification and the European Economic Area certification mark.
Health start-up SigTuple has raised $19m in series B funding led by existing investors Accel Partners and IDG Ventures, along with an undisclosed amount of venture debt from Trifecta Capital. The Indian-based AI company will use the funding to expand production of its AI100 smart device, which digitises biological samples such as blood, urine and semen. The company has applied for the US Food and Drug Administration certification and the European Economic Area certification mark.